Literature DB >> 19859985

Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors.

Sudha Balasubramanian1, Norbert Babai, Anathbandhu Chaudhuri, Fang Qiu, Sumitra Bhattacharya, Bhavana J Dave, Sowmya Parameswaran, Steve D Carson, Wallace B Thoreson, John G Sharp, Mahendra Rao, Iqbal Ahmad.   

Abstract

Direct reprogramming of differentiated cells to induced pluripotent stem (iPS) cells by ectopic expression of defined transcription factors (TFs) represents a significant breakthrough towards the use of stem cells in regenerative medicine (Takahashi and Yamanaka Cell 2006;126:663-676). However, the virus-mediated expression of exogenous transcription factors could be potentially harmful and, therefore, represents a barrier to the clinical use of iPS cells. Several approaches, ranging from plasmid-mediated TF expression to introduction of recombinant TFs (Yamanaka Cell 2009;137:13-17; Zhou, Wu, Joo et al. Cell Stem Cell 2009;4:381-384), have been reported to address the risk associated with viral integration. We describe an alternative strategy of reprogramming somatic progenitors entirely through the recruitment of endogenous genes without the introduction of genetic materials or exogenous factors. To this end, we reprogrammed accessible and renewable progenitors from the limbal epithelium of adult rat eye by microenvironment-based induction of endogenous iPS cell genes. Non cell-autonomous reprogramming generates cells that are pluripotent and capable of differentiating into functional neurons, cardiomyocytes, and hepatocytes, which may facilitate autologous cell therapy to treat degenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19859985     DOI: 10.1002/stem.242

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  15 in total

Review 1.  Research on induced pluripotent stem cells and the application in ocular tissues.

Authors:  Xiao-Ling Guo; Jian-Su Chen
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

2.  Differentiation potential of limbal fibroblasts and bone marrow mesenchymal stem cells to corneal epithelial cells.

Authors:  Kishore Reddy Katikireddy; Reza Dana; Ula V Jurkunas
Journal:  Stem Cells       Date:  2014-03       Impact factor: 6.277

3.  Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular degeneration.

Authors:  Iqbal Ahmad; Sudha Balasubramanian; Carolina B Del Debbio; Sowmya Parameswaran; Allen R Katz; Carol Toris; Robert N Fariss
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-02       Impact factor: 4.799

Review 4.  Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration.

Authors:  Hongjun Du; Siok Lam Lim; Seanna Grob; Kang Zhang
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

Review 5.  A review of the methods for human iPSC derivation.

Authors:  Nasir Malik; Mahendra S Rao
Journal:  Methods Mol Biol       Date:  2013

6.  Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy.

Authors:  Sowmya Parameswaran; Shashank Manohar Dravid; Pooja Teotia; Raghu R Krishnamoorthy; Fang Qiu; Carol Toris; John Morrison; Iqbal Ahmad
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

Review 7.  Stem cell therapy for retinal diseases: update.

Authors:  Rubens Camargo Siqueira
Journal:  Stem Cell Res Ther       Date:  2011-12-29       Impact factor: 6.832

Review 8.  Alternative sources of pluripotent stem cells: ethical and scientific issues revisited.

Authors:  Maureen L Condic; Mahendra Rao
Journal:  Stem Cells Dev       Date:  2010-08       Impact factor: 3.272

9.  A combined epigenetic and non-genetic approach for reprogramming human somatic cells.

Authors:  Jinnuo Han; Perminder S Sachdev; Kuldip S Sidhu
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

10.  Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat.

Authors:  Amanda-Jayne Carr; Anthony A Vugler; Sherry T Hikita; Jean M Lawrence; Carlos Gias; Li Li Chen; David E Buchholz; Ahmad Ahmado; Ma'ayan Semo; Matthew J K Smart; Shazeen Hasan; Lyndon da Cruz; Lincoln V Johnson; Dennis O Clegg; Pete J Coffey
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.